Return to List

Study Summary
No. 2005-0972:.......Gastrointestinal......Susan Peterson......Behavioral Science
.
Study Summary Title
Study Summary
Number:
2005-0972
Study Title:Colorectal Cancer (CRC) Screening Intervention for Relatives of CRC Patients
.
Physician New Patient Referral
Name:Susan PetersonPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Behavioral ScienceReferring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-8267
Contact us about clinical trials
.
General Information
Disease Group:GastrointestinalSupported By:N/A
Phase of Study:N/AReturn
Visit:
Not applicable.
Treatment
Agents:
NoneHome Care:Not applicable.
Treatment Loc:Independent Multicenter Arrangements
Estimated
Length of Stay
in Houston:
Not applicable.
Description/
Intervention:
.
Study Objectives / Outcomes
The purpose of this study is to find out whether different types of interventions improve attitudes regarding colorectal cancer and colorectal cancer screening among individuals who may be at increased risk for colorectal cancer because their sibling (brother or sister) was diagnosed with this disease. Specifically, this study will compare screening adherence of those who receive a generic print intervention, a tailored print intervention, and those who receive a tailored telephone counseling session and a tailored print intervention.

This study is an ongoing, NCI-funded, multi-site project. The lead institution is Fox Chase Cancer Center (FCCC). Siblings of colorectal cancer patients will be participants in the intervention study, and these siblings will be identified through patients seen at collaborating centers. As a collaborating site, MDACC will identify and contact colorectal cancer patients seen at our institution for subsequent identification and recruitment of their eligible siblings.

The primary aim of the study is:
1. To evaluate the impact of three interventions on colorectal cancer screening behaviors and intentions among siblings at increased familial risk for colorectal cancer: generic print intervention, a tailored print intervention, and a combined tailored print plus tailored telephone counseling intervention.

The secondary aims of the study are:
2. To determine whether demographic factors, medical access, physician recommendation at baseline, and colorectal cancer patient (proband) characteristics (e.g., stage of disease) moderate the impact of the interventions on colorectal screening.
3. To evaluate whether knowledge, attitude and physician recommendation variables mediate the association between the interventions and colorectal screening, and determine whether these variables are impacted by the interventions.
4. To analyze the cost of each intervention.
.
Study Status Information
Study Activation / Registration Date:02/28/2006
IRB Review and Approval Date:01/26/2006
Study Type:Cancer Control
Recruitment Status:Terminated
Projected Accrual:660 siblings, across all sites
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:1) CRC patient (proband) inclusion criteria: a) diagnosed with adenocarcinoma of the colon or rectum beginning in the year 1999 to the present; b) has at least one living sibling; c) age 18 to 60 years at CRC diagnosis, and, d) English speaking.

2) Participant (sibling) inclusion criteria: a) current age at or above 40 years OR at least 18 years old and within 10 years of the age at which the proband was initially diagnosed with CRC, whichever is the younger age, b) no personal history of colorectal cancer or colorectal polyps c) English speaking; d) not on schedule for colorectal cancer screening; e) has residential phone service.

Exclusion Criteria:1) CRC patient (proband) and participant (sibling) exclusion criteria: a) personal or family history of hereditary colorectal cancer, such as hereditary non-polyposis colorectal cancer or familial adenomatous polyposis, and b) history of inflammatory bowel disease.

.
Links
Registration Number: NCT00352638
Study Information on Clinical Trials Registry (clinicaltrials.gov)

Other Links:
.
Results


Return to Clinical Trials at M.D. Anderson Cancer Center